Members of our #TauConsortium recently contributed to a Nature Portfolio publication which set the foundation for a PET radiotracer trial in healthy adult patients.??? ? Learn more about how we support PET imaging through our medical research program to help improve its sensitivity and selectivity to identify different forms of tau through radiochemistry: https://lnkd.in/eTTFz-MA
The Rainwater Charitable Foundation
非盈利组织
Fort Worth，Texas 1,602 位关注者
Leading the Transformation of K-12 Education and Tauopathies Research
关于我们
The Rainwater Charitable Foundation (RCF) is a private family foundation based in Fort Worth, Texas. Founded by Richard E. Rainwater in 1991, RCF began as a nonprofit focused on funding initiatives centered around children, believing that high-quality education can transform their lives and the lives of their families. In 2009, RCF founded the Tau Consortium, to commission world-class research and drug discovery programs to accelerate treatments of tauopathies, a class of neurodegenerative diseases including supranuclear palsy and Alzheimer’s Disease. Today, RCF’s education grant focuses on funding the betterment of school-based work and systems, with the goals of affecting change in both neighborhoods and society as a whole. Additionally, since its founding of the Tau Consortium, RCF has invested approximately $100 million providing about 65% of all US philanthropic funding for tau-related research as well as created the Richard Rainwater Prize Program to reward innovative thinking and approaches to treatment. RCF is proud to be a leader in the fight against neurodegenerative diseases. Rainwatercharitablefoundation.org Follow us on Twitter: https://twitter.com/RCFNeuro
- 网站
-
https://rainwatercharitablefoundation.org
The Rainwater Charitable Foundation的外部链接
- 所属行业
- 非盈利组织
- 规模
- 11-50 人
- 总部
- Fort Worth，Texas
- 类型
- 非营利机构
- 创立
- 1991
地点
-
主要
获取路线
US，Texas，Fort Worth，76102
The Rainwater Charitable Foundation员工
动态
-
Last month, we had the pleasure of hosting our #TauConsortium investigators meeting (TCIM). The event kicked off with a patient-focused spotlight on ReDLat Dementia, a multi-partner initiative expanding dementia research in Latin America, and included an awe-inspiring session narrated by documentary photographer Alex Kornhuber showcasing the lived experiences of dementia patients and their families.? Science can be competitive and isolating, but our TCIM is a powerful reminder that collaboration is essential to advance research into primary tauopathies.? ? Read more about this year’s program: https://lnkd.in/etaG-QBw
-
-
We’re always searching for ways to help advance neurodegenerative research, such as CurePSP’s Pathway and Pipeline Grant Program. This program encourages researchers’ pursuit of new ideas that will help further our understanding of primary tauopathies by supporting the production of pilot studies that can eventually qualify for larger grants. It’s our hope that our contribution will help investigators explore their potentially groundbreaking ideas.? ? Learn more and apply for the program before October 3: https://lnkd.in/ebzrc7_Z
-
-
We convened a group of 35 experts in neurodegenerative research to implement a framework that may guide the translation of tauopathy therapeutics from discovery to early-phase clinical trials. With Howard Feldman leading the charge, experts applied the “5 Rights” of precision drug development in Alzheimer’s Disease to advise on how to de-risk common challenges and increase the likelihood of successful trials for critically needed new treatments for tauopathies. Explore the collaboration across industry, academia and non-profit organizations in the?Alzheimer's Association?’s?Alzheimer’s?& Dementia?Journal (open access): https://lnkd.in/exZWzf_A ? The Right Target? The Right Drug? The Right Biomarker? The Right Participants? The Right Trial?
-
-
As part of our work to advance neurodegenerative research, we’re excited to expand our partnership with?CurePSP?to support their Pathway and Pipeline Grant Program with a $200,000 contribution. We look forward to the program’s scientific impact as early-career researchers pursue potential cures for tauopathies including PSP and CBD.
CurePSP is pleased to announce receipt of a $200,000 contribution from The Rainwater Charitable Foundation (RCF), one of the largest independent funders of primary tauopathy research, enabling field-advancing programs and delivering crucial resources to a diverse set of collaborative researchers to support the organization's Pathway and Pipeline Grant Program. The contribution continues a string of partnerships between CurePSP and the RCF that hope to bring innovative ideas into clinical trials. "The RCF is excited to support promising early-career researchers who are exploring novel scientific approaches to address life-altering neurodegenerative diseases," said Glenn Harris, RCF director of research partnerships, business development and the drug discovery lead. "We look forward to tracking their scientific impact through the Pathway and Pipeline Grant Program and continuing to enable research that may ultimately lead to cures for these tauopathies." Read the full press release here: https://lnkd.in/eFqQVugq #CurePSP #BecauseHopeMatters #Research #PSP #MSA #CBD
-
This summer, the Rainwater Charitable Foundation and the Morton H. Meyerson Family Foundation brought together 41 Dream Big Determined Scholars for our fourth annual conference. From interactive presentations on the importance of finding mentors and building confidence, to sessions covering financial management and mental health, this event was packed with resources to help these exceptional students thrive in college and beyond. Curious about the impact of the #DreamBig scholars program and how we're supporting the next generation of leaders? Check out our latest blog post to learn more! https://lnkd.in/etSuYsqy
-
-
Tauopathy Challenge Workshop winners Dr. Yongku Cho and Dr. Jesse Rinehart are leveraging cutting-edge technology in pursuit of discovering better solutions for people living with neurodegenerative diseases. Their work recreates neuron cells in the lab through a modern science approach to study the modifications of the cells impacted by tau proteins to search for patterns.? ? See Drs. Cho and Rinehart’s technological approach to studying primary tauopathies: https://lnkd.in/eXgt8-pq
-
-
Congratulations to Dr. Martin Kampmann,?winner of the 2022 #RainwaterPrize for Innovative Early-Career Scientist and?a co-founder of Montara Therapeutics, Inc..?The company?recently?secured?$8 million?in?seed financing to expand?on its work?to?discover and develop brain-targeting drugs.?Explore our previous winners archive to learn why we honored Dr. Kampmann and others for their efforts:?https://lnkd.in/eZ33hZbZ.
Montara Therapeutics, a therapeutics company aiming to revolutionize the discovery and development of brain-targeting drugs, announced today the closing of an oversubscribed $8 million seed financing led by SV Health Investors’ Dementia Discovery Fund and co-lead Two Bear Capital. Dolby Family Ventures and KdT Ventures also participated in the round. UCSF Innovation Ventures congratulates Martin Kampmann and Kevan Shokat, the co-scientific founders! Find out more:https://lnkd.in/eQkam9sV #ucsf #brain #therapeutics
-
-
Listen as Dr. Virgina Man-Yee Lee—a 2024 #RainwaterPrize winner—discusses her research into the role of tau in neurodegenerative disorders on the “Expert Voices in Dementia” podcast. The funds from her 2024 Outstanding Innovation in Neurodegenerative Disease Research Prize will support her work investigating why only some patients diagnosed with progressive supranuclear palsy (PSP) report experiencing symptoms. https://lnkd.in/e5xW8HE7
Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders - The Neurology Hub
theneurologyhub.com
-
In partnership with CurePSP?and the Aging Mind Foundation, we’re supporting four pioneering research projects that surfaced during the inaugural Tauopathy Challenge Workshop with a total of $2 million in research grants. Learn more about our medical research program and how this funding will help neuroscientists advance tauopathy research in this Outsourcing Pharma article:?https://lnkd.in/dZexuYTi
Rainwater Foundation, CurePSP, Aging Mind Foundation fund innovative tauopathy research
outsourcing-pharma.com